Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1No longer available 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Endocrine 2Head & Neck 1CNS 1

Conditions

Insulinoma 4Hypoglycemia 4Congenital Hyperinsulinism 4Neuroendocrine Tumors 3Neuroblastoma 3Hyperinsulinism 3Pheochromocytoma 2Parkinson Disease 2Carcinoid Tumor 2Thyroid cancer, medullary 1Parathyroid Neoplasms 1Paraganglioma 1Multiple Endocrine Neoplasia 1Lewy Body Disease 1Infant, Newborn, Diseases 1Hyperparathyroidism 1Hypercalcemia 1Glucose Metabolism Disorders 1Endocrine System Diseases 1Brain Neoplasms 1Beckwith-Wiedemann Syndrome 1

Interventions

3-Iodobenzylguanidine 14Temozolomide 6lutetium Lu 177 dotatate 5gallium Ga 68 dotatate 4anlotinib 4Specimen Handling 4Everolimus 4Radiotherapy 3Phenoxybenzamine 3Magnetic Resonance Spectroscopy 3Doxorubicin 36-fluorodopamine 33-fluorobenzylguanidine 3pegfilgrastim 2olaparib 2fluorodopa F 18 2cabozantinib 2belzutifan 2Nivolumab 2Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Fluorodeoxyglucose F18 2Filgrastim 2Doxazosin 2Dexmedetomidine 2Capecitabine 2Biopsy 2Axitinib 2Adrenalectomy 2177Lu-octreotide, DOTA(0)-Tyr(3)- 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pheochromocytoma × fluorodopa F 18 × Endocrine × Clear all
NCT00004847 2026-06-03

Diagnosis of Pheochromocytoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
3,000 enrolled
Endocrine

Endocrine System Diseases, Pheochromocytoma

NCT02431715 2023-02-21

18F-FDOPA PET in Neuroendocrine Tumours

British Columbia Cancer Agency

No longer available
CNSEndocrineHead & Neck

Thyroid cancer, medullary, Carcinoid Tumor, Insulinoma, Neuroblastoma, Paraganglioma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡